Search results for "graine"

showing 10 items of 294 documents

Continuity of healthcare for headacahe patients: a problem of communication between headache specialists and general pratictioners

2005

The continuous care of headache patients, from headache centres to general practice, is a managerial problem that is still unsolved in Italy. In fact, if on the one hand patients do not usually go to headache centres because of poor information, on the other hand, if they do, they do not find their general practitioner (GP) sufficiently prepared to continue the management. In Sicily we have formed a dense network of headache centres that we will try to link on the Internet to deal with the problem of poor patients information and poor specialist consultation. We also have faced the problem of the continuous care, trying to overcome "the difficulties of communication between specialists, GPs…

medicine.medical_specialtyPain medicineClinical NeurologyMEDLINESpecialistContinuous healthcareGeneral practitionerHealth careMedicineHumansReferral and ConsultationSicilyMigraineId migraineHeadache diagnosisInternetbusiness.industryMigraine Specialist General practitioner ID–Migraine Headache portal Continuous healthcareCommunicationHeadacheGeneral MedicineContinuity of Patient Caremedicine.diseaseAnesthesiology and Pain MedicineMigraineNeurologyFamily medicineGeneral practiceHeadache and Continuity in Health CareID–MigraineThe InternetSettore MED/26 - NeurologiaNeurology (clinical)businessFamily PracticeHeadache portal
researchProduct

The Global Campaign (GC) to Reduce the Burden of Headache Worldwide. The International Team for Specialist Education (ITSE)

2005

The social perception of headache, everywhere at low levels in industrialised countries, becomes totally absent in developing ones. Headache disorders came into the World Health Organization’s strategic priorities after publication of the 2001 World Health Report. Among the leading causes of disability, migraine was ranked 19th for adults of both sexes together and 12th for females. The Global Campaign (GC) to Reduce the Burden of Headache Worldwide was planned by the major international headache organizations together with WHO in order to identify and remove those cultural, social and educational barriers recognised as responsible factors for the inadequate treatment of headache disorders …

medicine.medical_specialtyPain medicineeducationClinical SciencesGlobal Campaign Against HeadacheClinical NeurologyAlternative medicineMEDLINEWorld Health OrganizationGlobal Healthmasterin headache medicineWorld healthEducationMigrainesClinical ResearchMedicalacademic formation; global campaign against headache; headache specialist education; masterin headache medicineHealth careGeneticsGlobal healthHumansMedicineHeadache specialist educationDental/Oral and Craniofacial DiseaseGraduateNeurology & NeurosurgeryHeadachesbusiness.industrySocial perceptionPain ResearchHeadacheNeurosciencesMaster in Headache MedicineGeneral Medicinemedicine.diseaseHeadaches Physicians and PatientsAcademic formationQuality EducationAnesthesiology and Pain MedicineNeurologyMigraineEducation Medical GraduateFamily medicineNeurology (clinical)Chronic PainbusinessThe Journal of Headache and Pain
researchProduct

Osmophobia in migraine classification: a multicentre study in juvenile patients.

2010

Aims: This study was planned to investigate the diagnostic utility of osmophobia as criterion for migraine without aura (MO) as proposed in the Appendix (A1.1) of the International Classification of Headache Disorders (ICHD-II, 2004). Methods: We analysed 1020 patients presenting at 10 Italian juvenile headache centres, 622 affected by migraine (M) and 328 by tension-type headache (TTH); 70 were affected by headache not elsewhere classified (NEC) in ICHD-II. By using a semi-structured questionnaire, the prevalence of osmophobia was 26.9%, significantly higher in M than TTH patients (34.6% vs 14.3%). Results: Osmophobia was correlated with: (i) family history of M and osmophobia; and (ii) o…

medicine.medical_specialtyPediatricsAdolescentAuraMigraine Disordersosmophobia juvenile primary headache migraine without aura tension-type headache International Classification of Headache Disorder 2nd ednInternational Classification of Headache Disorder 2nd edn; Juvenile primary headache; Migraine without aura; Osmophobia; Tension-type headache;International Classification of Headache Disorder 2nd ednlaw.inventionRandomized controlled triallawInternational Classification of DiseasesSurveys and QuestionnairesmedicinePrevalenceJuvenileHumansFamily historyChildosmophobiabusiness.industryOsmophobiaKeywordsGeneral Medicinemedicine.diseasetension-type headachejuvenile primary headacheMulticenter studyMigrainemigraine without auraChild PreschoolOdorantsSensation DisordersPhysical therapyInternational Classification of Headache DisordersNeurology (clinical)businessCephalalgia : an international journal of headache
researchProduct

Headache attributed to head or neck trauma

2010

Publisher Summary This chapter presents an overview of all types of posttraumatic headache (PTH): acute PTH, chronic PTH, and headache after a whiplash injury, taking account of the definition and latest criteria of International Headache Classification II (ICHD-II). Headache is a symptom that may occur after injury to the head, neck, or brain. PTH is a cardinal symptom of the “postconcussion syndrome” and may be accompanied by somatic, psychological, or cognitive disturbances. PTH is always a new-onset headache resulting from brain, head, and sometimes neck injury, and can simulate the clinical characteristics of several primary headaches. Severe, moderate, and mild head injuries can cause…

medicine.medical_specialtyPediatricsbusiness.industryPostconcussion syndromemedicine.diseasePrimary headacheMigraineNeck injurymedicineWhiplashPhysical therapyHeadachesmedicine.symptombusinessPosttraumatic headacheNeck trauma
researchProduct

Migraine Headaches in a High School Student Population.

1991

medicine.medical_specialtyStudent populationMigrainebusiness.industrymedicineNeurology (clinical)General MedicineHeadachesmedicine.symptomPsychiatrymedicine.diseasebusinessCephalalgia
researchProduct

Transverse Sinus Stenosis in Refractory Chronic Headache Patients: An Observational Study

2019

Background: Transverse sinus stenosis is a common brain MRI finding in chronic migraine (CM) and chronic tension-type headache (CTTH) patients in clinical practice; however, its clinical and diagnostic role is unclear. The aim of the study is to determine the frequency of transverse sinus stenosis in these headache patients resistant to preventive treatments and to verify whether this is a useful finding for identifying patients with intracranial hypertension. Methods: This is an observational study. Patients with refractory CM and CTTH underwent a 3T-magnetic resonance venography (MRV) before cerebrospinal fluid (CSF) opening pressure measurement. Transverse sinus stenosis was determined u…

medicine.medical_specialtyVenographylcsh:RC346-429030218 nuclear medicine & medical imaging03 medical and health sciences0302 clinical medicineCerebrospinal fluidChronic Migrainechronic headacheInternal medicinemedicineRisk factorlcsh:Neurology. Diseases of the nervous systemSinus (anatomy)Original Researchmedicine.diagnostic_testbusiness.industrysinus stenosisrefractory headachemedicine.diseaseComorbidityStenosismedicine.anatomical_structureNeurologyConcomitantCardiologyNeurology (clinical)businessidiopathic intracranial hypertension030217 neurology & neurosurgeryMRIFrontiers in Neurology
researchProduct

Autism and Migraine: An Unexplored Association?

2020

Autism spectrum disorder is characterized by neurological, psychiatric and medical comorbidities—some conditions co-occur so frequently that comorbidity in autism is the rule rather than the exception. The most common autism co-occurring conditions are intellectual disability, language disorders, attention-deficit hyperactivity disorder, epilepsy, gastrointestinal problems, sleep disorders, anxiety, depression, obsessive-compulsive disorder, psychotic disorders, oppositional defiant disorder, and eating disorders. They are well known and studied. Migraine is the most common brain disease in the world, but surprisingly only a few studies investigate the comorbidity between autism and migrain…

medicine.medical_specialtyautismReviewbehavioral disciplines and activitiesASDlcsh:RC321-57103 medical and health sciencesEpilepsy0302 clinical medicineIntellectual disabilitymental disordersmedicinemigrainepainPsychiatrylcsh:Neurosciences. Biological psychiatry. Neuropsychiatry030304 developmental biology0303 health sciencesbusiness.industryGeneral Neurosciencemedicine.diseaseComorbidityEating disordersMigraineAutism spectrum disorderAutismAnxietymedicine.symptombusinessheadache030217 neurology & neurosurgeryBrain Sciences
researchProduct

When to use frovatriptan in migraine? A reply

2011

Dear Sir, We read with interest the comments of Dr. Tfelt-Hansen [1] on the two recently published randomized controlled trials comparing patients’ preference (primary end-point) and efficacy (secondary end-points) of frovatriptan with respect to rizatriptan [2] and almotriptan [3]. In both studies, frovatriptan showed similar preference and short-term efficacy outcomes (pain relief and pain free episodes at 2 h) with respect to the other two triptans. The principal concern of Dr. Tfelt-Hansen was the very early use of frovatriptan in these studies, making their results hardly comparable with those of previous randomized controlled trials [4–6], where patients waited until the headache was …

medicine.medical_specialtybusiness.industryClinical NeurologyGeneral MedicineTriptansPlacebomedicine.diseaseRizatriptanlaw.inventionSumatriptanAnesthesiology and Pain MedicineRandomized controlled trialMigrainelawAlmotriptanInternal medicineMedicineMigraine Frovatriptan Almotriptan Patient preferenceNeurology (clinical)businessPsychiatryFrovatriptanLetter to the Editormedicine.drug
researchProduct

Suggested randomized, controlled trial for frovatriptan: a reply

2011

Dear Sir, We read with interest the comments of Dr. Tfelt-Hansen [1] regarding our three recently published randomized controlled trials comparing patients’ preference (primary endpoint) and efficacy (secondary endpoints) of frovatriptan 2.5 mg versus zolmitriptan 2.5 mg [2], rizatriptan 10 mg [3] and almotriptan 12.5 mg [4], and the meta-analysis of pooled individual data from the three studies [5]. In all studies frovatriptan showed similar preference and short-term efficacy outcomes (pain relief and pain-free episodes at 2 h) with respect to the other three triptans. The questions put by Dr. Tfelt-Hansen sound appropriate. Doubts are raised on the usefulness of head-to-head preference tr…

medicine.medical_specialtybusiness.industryClinical NeurologyZolmitriptanGeneral MedicineTriptansmedicine.diseaseRizatriptanEfficacySumatriptanAnesthesiology and Pain MedicineMigraineAlmotriptanmedicinefrovatriptan controlled trial migraineNeurology (clinical)Intensive care medicinebusinessFrovatriptanLetter to the Editormedicine.drugThe Journal of Headache and Pain
researchProduct

11th European Headache Federation Congress jointly with 31st Congress of the Italian Society for the Study of Headaches : Rome, Italy. 01-03 December…

2017

. Aims of the study were explore the relationship between peripheral chromatic and central visual dysfunction evaluating also the presence of functional receptor impairment in patients with migraine, with and without aura examined interictally.

medicine.medical_specialtybusiness.industryGeneral MedicineIndividual riskmedicine.diseaseAnesthesiology and Pain MedicineMigraineInternal medicinemedicinecentral visual processingAbnormal peripheral visual processingmigraineNeurology (clinical)Headachesmedicine.symptombusiness
researchProduct